Page 5 - Nasdaq Snce News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nasdaq snce. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nasdaq Snce Today - Breaking & Trending Today

Critical Contrast: Science 37 (SNCE) & Its Competitors

Science 37 (NASDAQ:SNCE – Get Rating) is one of 41 publicly-traded companies in the “Commercial physical research” industry, but how does it contrast to its competitors? We will compare Science 37 to related businesses based on the strength of its dividends, risk, institutional ownership, earnings, analyst recommendations, profitability and valuation. Valuation & Earnings This table […] ....

North Carolina , United States , Research Triangle Park , Holdings Inc , Get Rating , Given Science , Science 37 , Nasdaq Snce , Stock Comparison , Stock Analysis ,

Science 37 and NuvoAir Partner to Bring Patient-Centric

By following the patient, home-based data collection enables more clinical trials to adopt agile (hybrid) and fully decentralized approaches.. ....

United States , David Coman , Holdings Inc , Agile Clinical Trial Operating System , Chief Executive Officer , Lorenzo Consoli , Operating System , Nasdaq Snce , Science 37 ,

Science 37 (NASDAQ:SNCE) & SomaLogic (NASDAQ:SLGC) Critical Analysis

Science 37 (NASDAQ:SNCE – Get Rating) and SomaLogic (NASDAQ:SLGC – Get Rating) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, institutional ownership, profitability, valuation, risk, dividends and earnings. Profitability This table compares Science 37 and SomaLogic’s net margins, […] ....

United States , North Carolina , Research Triangle Park , Somamers Somascan , Holdings Inc , Somalogic Inc , Get Rating , Given Science , Science 37 , Nasdaq Snce , Stock Comparison , Stock Analysis ,

Oncology Clinical Trial Execs to Increase Decentralization,

Almost three in four (73%) oncology research executives plan to execute either a fully decentralized or hybrid clinical trial in the next 12 months. ....

Holdings Inc , Oncology Research , Agile Clinical Trial Operating System , Shaalan Beg , Vice President , How Agile Clinical Trials , Impacting Oncology , Drew Bustos , Chief Strategy Officer , Patient Recruitment , Study Start Up , Increased Patient Retention , Greater Patient Diversity , Faster Patient Recruitment , Operating System , Nasdaq Snce , Science 37 ,

Science 37® to Participate in Upcoming Investor Conferences

RESEARCH TRIANGLE PARK, N.C., June 07, 2022 (GLOBE NEWSWIRE) Science 37 Holdings, Inc. (Nasdaq: SNCE), the Agile Clinical Trial Operating System™,. ....

Holdings Inc , Gilmartin Group , Agile Clinical Trial Operating System , Partners Summer , Annual Futurehealth , Clinical Trials , Operating System , Nasdaq Snce , Science 37 ,